GOP Returns to Power: How the 2024 Election Outcomes Could Affect the 340B Program

Former President Donald Trump's (R) victory in Tuesday’s presidential election could have significant implications for the 340B program.
Former President Donald Trump’s victory over Democratic Vice President Kamala Harris in Tuesday’s presidential election capped a series of high-profile [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Proposition 34: Results Too Close to Call in Controversial California 340B Ballot Measure Contest

California voters weighed-in on Proposition 34, a controversial 340B-related ballot measure in the Nov. 5 elections.
With just over half of the expected vote total counted, it’s too early to tell whether California voters will approve [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in West Virginia, Missouri, Kansas

Key briefs were filed this week in state contract pharmacy litigation in West Virginia, Missouri and Kansas.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

November 5 is Finally Here: How the 2024 Elections Could Affect the 340B Program

Voters will cast ballots in Tuesday's presidential contest between Vice President Kamala Harris (D) and former President Donald Trump (R).
When voters across the U.S. cast their ballots in Tuesday’s elections, they will not just be deciding who will control [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HHS Appeals Court Ruling That Blocked DSH Calculation Changes That Impact 340B Eligibility

The 5th Circuit Court of Appeals will take up a case that Texas hospitals filed against HHS to block changes to how the Medicare DSH payment calculation is determined.
The Biden Administration has asked a federal appeals court to reconsider a Texas judge’s ruling that voided a Department of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Former Presidential Candidate Howard Dean Calls for More 340B Transparency, Declines to Discuss Op-ed, Alleged Drug Industry Ties

Howard Dean urged federal lawmakers in an Oct. 25 RealClearHealth op-ed to pay attention to the 340B program.
A high-profile former Vermont governor with reported drug industry ties took aim at hospitals’ use of 340B savings, calling for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Organon To Extend Contract Pharmacy Restrictions to CHCs on Dec. 1

Organon announced that, effective Dec. 1, it will extend its contract pharmacy restrictions to HRSA-funded health centers.
A New Jersey-based drugmaker announced this week that beginning in December, its 340B contract pharmacy restrictions will apply to Health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Minnesota, Missouri, Mississippi

Key briefs were filed this week in state contract pharmacy litigation in Minnesota, Missouri and Mississippi.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Group That Does Not Disclose Its Funding Releases White Paper Calling for 340B Reforms, Advocates Slam Report

The Health Equity Collaborative called for 340B program overhauls in a new white paper.
An organization that describes itself as being “comprised of dozens of national, public health, patient advocacy and multicultural organizations,” but [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Lobbying Activity Did Not Slow Down in Q3, Federal Filings Suggest

340B Working Table
More than 360 firms reported lobbying on the 340B program between July 1 and Sept. 30.
The 340B drug discount program continued to be a hot topic for lobbyists in the third quarter of 2024, keeping [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »